AMA
Moniuszko A, Rydzewska G. The effect of cyclic rifaximin therapy on symptoms of diverticular disease from the perspective of the gastroenterology outpatient clinic: a “real-life” study. Gastroenterology Review/Przegląd Gastroenterologiczny. 2017;12(2):145-151. doi:10.5114/pg.2017.68167.
APA
Moniuszko, A., & Rydzewska, G. (2017). The effect of cyclic rifaximin therapy on symptoms of diverticular disease from the perspective of the gastroenterology outpatient clinic: a “real-life” study. Gastroenterology Review/Przegląd Gastroenterologiczny, 12(2), 145-151. https://doi.org/10.5114/pg.2017.68167
Chicago
Moniuszko, Andrzej, and Grażyna Rydzewska. 2017. "The effect of cyclic rifaximin therapy on symptoms of diverticular disease from the perspective of the gastroenterology outpatient clinic: a “real-life” study". Gastroenterology Review/Przegląd Gastroenterologiczny 12 (2): 145-151. doi:10.5114/pg.2017.68167.
Harvard
Moniuszko, A., and Rydzewska, G. (2017). The effect of cyclic rifaximin therapy on symptoms of diverticular disease from the perspective of the gastroenterology outpatient clinic: a “real-life” study. Gastroenterology Review/Przegląd Gastroenterologiczny, 12(2), pp.145-151. https://doi.org/10.5114/pg.2017.68167
MLA
Moniuszko, Andrzej et al. "The effect of cyclic rifaximin therapy on symptoms of diverticular disease from the perspective of the gastroenterology outpatient clinic: a “real-life” study." Gastroenterology Review/Przegląd Gastroenterologiczny, vol. 12, no. 2, 2017, pp. 145-151. doi:10.5114/pg.2017.68167.
Vancouver
Moniuszko A, Rydzewska G. The effect of cyclic rifaximin therapy on symptoms of diverticular disease from the perspective of the gastroenterology outpatient clinic: a “real-life” study. Gastroenterology Review/Przegląd Gastroenterologiczny. 2017;12(2):145-151. doi:10.5114/pg.2017.68167.
